How to Make Immunotherapy an Effective Therapeutic Choice for Uveal Melanoma

SIMPLE SUMMARY: Despite improvements in the early identification and successful control of primary uveal melanoma, 50% of patients will develop metastatic disease with only marginal improvements in survival. This review focuses on the tumor microenvironment and the cross-talk between tumor and immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Marseglia, Mariarosaria, Amaro, Adriana, Solari, Nicola, Gangemi, Rosaria, Croce, Elena, Tanda, Enrica Teresa, Spagnolo, Francesco, Filaci, Gilberto, Pfeffer, Ulrich, Croce, Michela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122936/
https://www.ncbi.nlm.nih.gov/pubmed/33922591
http://dx.doi.org/10.3390/cancers13092043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122936/
https://www.ncbi.nlm.nih.gov/pubmed/33922591
http://dx.doi.org/10.3390/cancers13092043

Ejemplares similares